1. Background {#sec0001}
=============

In December 2019, a novel coronavirus was introduced, causing viral pneumonia and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ([@bib0001]). The outbreak spread from China to 24 other countries within a few weeks ([@bib0002]).

In Iran, the first COVID-19 related death was announced on Feb 19, 2020 ([@bib0003]). The incidence of the disease is high in Iran (4.6 per 1000,000) ([@bib0004]). Since Iran is one of the countries with a high prevalence of COVID-19, people\'s knowledge and attitude play important roles in preventing the disease. The issue is even more prominent for patients who receive immunomodulatory or immunosuppressive agents, like for MS patients. MS patients use disease-modifying therapies (DMTs) to control relapses and to decrease the progression of the disease ([@bib0005]; [@bib0006]), which predisposes them to the increased risk of infections ([@bib0007]).

Due to the importance of considering safety tips among MS patients, we designed this study to assess the knowledge of MS patients regarding the COVID-19 pandemic in Iran.

2. Methods {#sec0002}
==========

This cross-sectional study was conducted in the MS clinic of Tehran University of Medical Sciences in March 2020.

Inclusion criteria were age greater than 18, definite MS diagnosis based on 2017 McDonald criteria, and the ability to fill online forms (having access to social media).

The patients were firstly asked for their consent before starting the questions.

We developed a google form including basic demographic questions (age, sex, type of MS, duration of the disease, occupation, type of medication, and educational level) and questions specifically related to COVID-19, asking about quarantine rules, countries, symptoms, prevention strategies, risk of infection in children, Iran situation compared to other infected countries, and the individual\'s role in preventing the disease.

Patients were grouped based on age (≤30 or ≥30) and educational level (academic versus non-academic). Data was presented as Mean ± SD for continuous variables and as frequencies for categorical variables. The chi-square test was used for comparison between qualitative variables.

3. Results {#sec0003}
==========

Within three days, 233 filled forms were gathered. The mean age and years of education were 34.2 ± 8 and 13.3 ± 4.8 years, respectively. One hundred and eighty forms belonged to females (F/*M* = 3.3). The most common medication used was rituximab ([Table 1](#tbl0001){ref-type="table"} ).Table 1Basic characteristics of the patients.Table 1VariablesAge (mean ±SD)(year)34.2 ± 8SexMale53(22.7%)Female180(77.3%)Type of MSRR168(72.1%)Progressive (PP and SP)65(27.9%)Duration of the disease (mean ±SD) (year)7.4 ± 5Education (mean ±SD) (year)13.3 ± 4.8OccupationEmployed135(57.9%)Unemployed98(42.1%)Type of MedicationINF69(29.6%)GA24(10.3%)Fingolimod24(10.3%)Triflunomid1(0.4%)Tysabri1(0.4%)Rituximab83(35.6%)DMF20(8.6%)Ocrelizumab2(0.9%)No medication at the time of study9(3.9%)[^2]

Ninety percent knew that COVID-19 is in a pandemic stage, and 73% followed quarantine guidelines completely. All participants believed that the virus has a high person-to-person transmission rate ([Table 2](#tbl0002){ref-type="table"} ).Table 2Findings of the questionnaire.Table 2**At which phase do you think the COVID-19 is currently?Epidemic**18 (7.7%)**Endemic**5 (2.1%)**Pandemic**210 (90.1%)**Can gloves and masks still protect people from coronavirus?Yes**209 (89.7%)**No**24 (10.3%)**How much do you follow quarantine guidelines?Completely**170 (73%)**Almost**62 (26.6%)**Never**1 (0.4%)**Do you think travel restrictions can prevent coronavirus?Yes**231 (99.1%)**No**2 (0.9%)**Do you think Iran is among severely affected countries?Yes**223 (95.7%)**No**10 (4.3%)**Do you think borders closure is helpful to prevent the disease?Yes**228 (97.9%)**No**5 (2.1%)**Do you think shutting down crowded places like museums and shopping malls is helpful?Yes**223 (100%)**NoCan kids catch COVID-19?Yes**201 (86.3%)**No**32 (13.7%)**Do all affected people have severe symptoms like continuous cough or high fever?Yes**46 (19.7%)**No**187 (80.3%)**Do you think ignoring quarantine guidelines can contribute to the outbreak of the disease?Yes**230 (98.7%)**No**3 (1.3%)**Does Coronavirus have a high person-to-person transmission rate?YesNo**233 (100%)**How effective do you think is your role in preventing the spread of the virus?A little**19(8.2%)**Moderately**65(27.9%)**A lot**149(63.9%)

The answers to the questionnaire did not show significant differences comparing sex, age (≤30 or ≥30), or educational level (≤ 12 or ≥12 years) of the respondents. But the difference was significant between relapsing-remitting and progressive MS patients regarding the extent to which they follow quarantine guidelines. Most patients with relapsing-remitting form of the disease followed quarantine rules completely, while one patient with progressive form did not follow the rules at all ([Table 3](#tbl0003){ref-type="table"} ).Table 3Comparison between relapsing-remitting and progressive groups.Table 3RR formProgressive formP valueHow much do you follow quarantine guidelines?Completely132(78.6%)38(58.5%)0.004Almost36(21.4%)26(40%)Never01(1.5%)

4. Discussion {#sec0004}
=============

According to our results, 90% of the enrolled patients were aware of the severity of the disease (the pandemic stage) and the protective role of gloves and masks. This level of awareness might be due to the notifications from social media, such as the MS society Telegram channel and website, through which physicians inform their patients daily about prevention rules and disease control strategies.

We also found that although all individuals knew about high person-to-person transmission rate of the infection, 73% followed quarantine rules completely. Immunomodulatory or immunosuppressive agents that are used by MS cases, expose them to a higher risk of infection, so it is crucial for them to carefully follow quarantine rules ([@bib0007]).

Implementing preventive strategies is an important factor to control COVID-19 spread. A high-level quarantine is recommended in this health security emergency ([@bib0008]). Quarantine is an old method of controlling a communicable disease outbreak, successfully used for the SARS epidemic in 2003 ([@bib0009]). Currently, quarantine is mandatory in most countries and people are asked to follow the guidelines. It is more essential for high-risk groups such as elderlies, individuals with underlying diseases, and children.

All the respondents believed that closing crowded places, such as museums, is effective and 97% thought borders closure is helpful.

No significant differences were found between age, sex, and educational level groups. However, comparing MS patients with the relapsing-remitting form (RRMS) of the disease and those with progressive form, RRMSs took quarantine rules more seriously.

Patients with progressive MS have more disability rates, so it would be more exhausting for them to stay at home for a long time. They also need more health care, which may require visiting health professionals or referring to a hospital. Patients with progressive MS are more depressed and are less socially active ([@bib0010]), while for RRMS patients, it is important to stay active and return to normal life. So, RRMS patients follow quarantine rules more carefully.

5. Conclusion {#sec0005}
=============

Patients with MS have a good understanding of the COVID-19 stage, while about one-third do not follow quarantine rules completely.
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